Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Romanos Sklavenitis Pistofidis, M.D.

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma9202251461.120 Why?
HMGA1a Protein12021610.740 Why?
Waldenstrom Macroglobulinemia3202110730.510 Why?
Receptors, CXCR4120187270.450 Why?
RNA-Binding Proteins1202118980.400 Why?
Adaptor Proteins, Signal Transducing1202128980.360 Why?
Monoclonal Gammopathy of Undetermined Significance220201790.290 Why?
Gene Expression Regulation, Neoplastic1202185540.240 Why?
Neoplasm Recurrence, Local1202192800.210 Why?
Disease Models, Animal12021182550.190 Why?
Bone Marrow3202129110.190 Why?
Immunologic Factors2202215900.190 Why?
Clinical Trials, Phase II as Topic120226290.170 Why?
Disease Progression52022135100.160 Why?
Receptor, Interferon alpha-beta120181120.150 Why?
Plasma Cells120215990.150 Why?
Sequence Analysis, RNA2202120210.130 Why?
Mice, SCID1202126260.130 Why?
Stromal Cells1202113300.130 Why?
Mutation22019300530.120 Why?
Clone Cells1201816590.120 Why?
Cell Adhesion1202130880.120 Why?
Cell Proliferation22021104510.110 Why?
Tumor Cells, Cultured1202161310.110 Why?
Neoplasms, Experimental1201812290.100 Why?
Chromosome Aberrations1201817680.100 Why?
Tumor Microenvironment2202138780.090 Why?
Neoplasms, Second Primary1201810520.090 Why?
Antibodies, Viral1202131560.090 Why?
Base Sequence12021124410.080 Why?
Immunoglobulin G1202145440.080 Why?
Survival Rate22021127230.080 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1201815510.080 Why?
Immune Tolerance1201823020.080 Why?
Cell Movement1202152050.080 Why?
Decision Support Techniques1201919980.080 Why?
High-Throughput Nucleotide Sequencing1202036390.070 Why?
Asymptomatic Diseases220215880.070 Why?
Immunotherapy1202246520.070 Why?
Neoplasm Proteins1201836170.060 Why?
Prognosis32021296290.060 Why?
Apoptosis1202194900.060 Why?
T-Lymphocytes, Regulatory1201830800.060 Why?
Genomics1202058210.060 Why?
Humans1220227615960.060 Why?
Follow-Up Studies32019391060.050 Why?
Immunologic Tests120211040.050 Why?
Hematopoietic Stem Cell Transplantation1201856720.040 Why?
Risk2202296100.040 Why?
Models, Immunological120215130.040 Why?
Mice32021815390.040 Why?
beta 2-Microglobulin120193290.040 Why?
Antibodies, Blocking120182430.040 Why?
Antibodies, Neoplasm120182810.030 Why?
Female620213927050.030 Why?
Immunocompromised Host120218580.030 Why?
Myeloid Differentiation Factor 88120195870.030 Why?
Animals320211684750.030 Why?
Immunoglobulin M1201915260.030 Why?
Risk Factors42022742130.030 Why?
Male520213608460.020 Why?
Transplantation, Homologous1201848070.020 Why?
Disease-Free Survival1201968150.020 Why?
Biopsy1201967660.020 Why?
Combined Modality Therapy1201885270.020 Why?
Boston1201993270.020 Why?
Aged, 80 and over22020589840.010 Why?
Phenotype12022165920.010 Why?
Cell Line12018156010.010 Why?
Mice, Knockout12018144170.010 Why?
Predictive Value of Tests12019152660.010 Why?
Aged320201693100.010 Why?
Middle Aged320202209210.010 Why?
Adult320202212100.010 Why?
Risk Assessment12019239960.010 Why?
Time Factors12019399690.010 Why?
Prospective Studies12021544230.010 Why?
Signal Transduction12018234470.010 Why?
Sklavenitis Pistofidis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.